Humanin vs MOTS-c
Updated 9 sources
Key differences
- 1Both come from mitochondrial DNA: humanin from the 16S rRNA gene (MT-RNR2), MOTS-c from the 12S rRNA gene.
- 2Humanin works mainly against cell death and through IGF-1 signalling; MOTS-c works through AMPK and acts like an exercise signal.
- 3For fat loss or insulin sensitivity, one guide says the evidence weight sits with MOTS-c.
Side by side
Facts from each record, in the same words as their own pages.
| Humanin | MOTS-c | |
|---|---|---|
| Category |
|
|
| Evidence |
|
|
| FDA status |
|
|
| WADA |
|
|
| Half-life |
|
|
| Routes |
|
|
| Forms |
|
|
| Reported doses |
|
|
| Most cited frequency |
|
|
| Vial sizes |
|
|
| Mixed vial keeps |
|
|
| Protocols on file |
|
|
Doses shown are what sources report, labelled by origin. Not medical advice.
Read each in full
Sources
9 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.
Clinical study3
- Yen K et al. 2020, full textPubMed Central · checked Oct 24, 2026
- Chin YP et al. 2013, Pharmacokinetics and tissue distribution of humanin and its analogues in male rodents, EndocrinologyPubMed · checked Oct 24, 2026
- PubMed search: MOTS-c pharmacokinetics or half-lifePubMed · checked Oct 23, 2026
Regulatory3
- FDA briefing document, PCAC July 23 to 24, 2026: MOTS-cFDA · checked Oct 23, 2026
- Bulk drug substances nominated for use in compounding under section 503A (interim categories 1 to 3)FDA · checked Oct 24, 2026
- Certain bulk drug substances for use in compounding that may present significant safety risksFDA · checked Oct 24, 2026
Competitor guide3
- Humanin peptide: what the 2026 research actually showspeptidedeck.com · checked Oct 24, 2026
- Humanin peptide: benefits, dosing, safetypeptidesexplorer.com · checked Oct 24, 2026
- Humaninpeptiq.io · checked Oct 24, 2026